348 results on '"Kim, Seungtaek"'
Search Results
2. DeepGT: Deep learning-based quantification of nanosized bioparticles in bright-field micrographs of Gires-Tournois biosensor
3. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
4. Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation
5. Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses
6. Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
7. Synthesis and structure–activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2
8. Diagnostic performance and clinical feasibility of a novel one-step RT-qPCR assay for simultaneous detection of multiple severe acute respiratory syndrome coronaviruses
9. Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic
10. Vehicle Path Tracking Control Using Pure Pursuit With MPC-Based Look-Ahead Distance Optimization
11. Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
12. Thermal Dynamics of a Novel Radio-Frequency Device for Endoscopic Spine Surgery: An Experimental Model
13. A Randomized Trial of Nafamostat for Covid-19
14. Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]
15. Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
16. Discovery of 2-aminoquinolone acid derivatives as potent inhibitors of SARS-CoV-2
17. Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
18. Imitation Learning of Nonlinear Model Predictive Control for Emergency Collision Avoidance
19. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
20. Imitation Learning of Nonlinear Model Predictive Control for Emergency Collision Avoidance
21. Deepgt: Deep Learning-Based Quantification of Nanosized Bioparticles in Bright-Field Micrographs of Gires-Tournois Biosensor
22. Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay
23. Quick Light-Mixing for Image Inspection Using Simplex Search and Robust Parameter Design
24. Optimal RGB Light-Mixing for Image Acquisition Using Random Search and Robust Parameter Design
25. Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
26. No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
27. Lancemaside A from Codonopsis lanceolata is a broad-spectrum antiviral agent against SARS-CoV-2 and variants of concern
28. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
29. Targeting the Receptor-Binding Motif of SARS-CoV-2 with D-Peptides Mimicking the ACE2 Binding Helix: Lessons for Inhibiting Omicron and Future Variants of Concern
30. Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties
31. Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model.
32. Quick light mixing of multiple color sources for image acquisition using pattern search
33. Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination
34. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2
35. Cell Culture-Adaptive Mutations of NS5A Affect Replication of Hepatitis C Virus Differentially Depending on the Viral Genotypes
36. Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2
37. Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 Entry
38. COVID-19 Drug Development
39. Synthesis and biological evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one derivatives as a potential treatment for SARS‐CoV‐2
40. Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without
41. Starch Biosynthetic Enzymes from Developing Maize Endosperm Associate in Multisubunit Complexes
42. Involvement of Host Cellular Multivesicular Body Functions in Hepatitis B Virus Budding
43. Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections
44. Diagnostic Performance and Clinical Feasibility of a Novel One-Step RT-qPCR for Detecting Multiple Severe Acute Respiratory Syndrome Coronavirus
45. Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2
46. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation
47. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses
48. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy
49. Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments
50. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.